Who We Are
Oyster Venture Partners consists of a multi-disciplinary team of highly experienced operational deal makers who have worked across the biotechnology, therapeutic, diagnostic, medical technology, digital healthcare and healthcare
sectors around the globe. Our culture centres on closely partnering our client base, throughout the capital raising process supporting all levels of experienced leaders with a wide range of funding and corporate transactions.
Meet the Team
Management Team
David D’Alton
Executive Chairman
40 years’ international business development experience in corporate information technology (IBM and DECorp), and in Life Sciences in SME-level innovation. Oyster co-founder and lead sponsor of Oyster’s unique platform solution to accelerate investment capital raising processes.
+44 7836 22 44 22
Rupert Lewis
Chief Executive Officer
25+ years’ of international corporate transaction experience, with a driving passion for supporting innovation in healthcare. Oyster co-founder and lead sponsor of Oyster’s unique platform solution to accelerate investment capital raising processes.
+44 7860 640 444
Sarah Taylor, MA, FCIPD
Chief People Officer
International Board level experience in FTSE companies, Investment Banking & Private Equity gained in Professional Services, Life Sciences and the TIC (Testing, Inspection & Certification) sectors. Leading Oyster’s commercial and scientific Advisory Boards development strategies.
+44 7725 782 116
Venture Partner Team
Kris Motmans, PhD
Venture Partner – Biotechnology
Serial senior advisor within Life Sciences, covering both public and private transactions, investment sourcing and completions, also inter alia CBO to a contract research organisation, formerly MD to a project management company, corporate development adviser to a cell therapy company.
+32 473 71 56 88
Carl Weir, B.Comm
Venture Partner & CDO – Digital Health & Data Valuation
Serial digital transformation/product strategy innovator in finance, legal, AI, ML, Big Data, blockchain, payments, digital healthcare and data valuation. Significant investment banking background – HSBC, ABN AMRO, Credit Suisse, Barclays, Westpac, Wall Street Systems
+44 7515 551 484
Aswad Martin, MSc, BSc
Chief
Mathematician
An accomplished Data Scientist with a background in statistical analysis including hypothesis testing, data manipulation and exploratory data analysis, backed by object-oriented programming, now a key contributor to Oyster’s new growing Data Valuation business.
+44 77957 669 692
Business Engagement Team
Benny Daniëls, MSc
Business Engagement & Scientific Advisory Lead
40 years’ corporate / SME business development and consulting experience in US, Scandinavia, Baltics, UK and India. Strong biopharmaceutical industry history (GSK Biologics, Johnson & Johnson) in immuno-biologicals, personalised medicines and small molecules.
+32 475 36 49 96
Charlotte Wuyts, MSc, BSc
Business Engagement Analyst
Experienced with cell-derived extracellular vesicles as a nanotherapeutic for multiple sclerosis amongst several other indications, including RNA extraction and qPCR techniques, a passionate business developer in the preclinical research services business, and new business evaluator.
+32 472 97 38 22
Analyst Team
Kaarel Aulik, FVMA
Senior Analyst
10+ years’ experience within the healthcare sector (Johnson & Johnson), supporting strategic decision-making through market analytics and insight generation. Leading Oyster’s database stratification to fast track the matching of founder to funder.
+44 7496 847 156
Ethan Von Fintel
Junior Analyst
Business management graduate with a background in enterprise architecture, data analytics, and cyber resilience. Supporting Oyster’s campaign engine focussed on investor engagement and fast track matching of founder to funder.